How Adequate is Adequate for the Collection of Endocervical Specimens for Chlamydia trachomatis Testing?

Background: Endocervical specimen adequacy has been assessed by subjective criteria that are based on arbitrarily chosen thresholds for the presence of target cells observed on microscopic slide examinations. Goal of this Study: To assess the relationship of chlamydia test positivity to specimen ade...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Sexually transmitted diseases 1999-11, Vol.26 (10), p.579-583
Hauptverfasser: BEEBE, JAMES L., GERSHMAN, KENNETH A., KELLEY, JAMES K., HAGNER, DINAH, CREEDE, PAUL
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 583
container_issue 10
container_start_page 579
container_title Sexually transmitted diseases
container_volume 26
creator BEEBE, JAMES L.
GERSHMAN, KENNETH A.
KELLEY, JAMES K.
HAGNER, DINAH
CREEDE, PAUL
description Background: Endocervical specimen adequacy has been assessed by subjective criteria that are based on arbitrarily chosen thresholds for the presence of target cells observed on microscopic slide examinations. Goal of this Study: To assess the relationship of chlamydia test positivity to specimen adequacy with the use of a semiquantitative cytologie staining method for assessing endocervical specimen collection cellularity. Study Design: Endocervical specimens for chlamydia testing (PACE 2, GenProbe, San Diego, CA) and for a slide cytologie examination (n = 3,500) were collected in parallel. A semiquantitative cytologie examination to determine a specimen adequacy (SA) score was performed for every chlamydiapositive result (n = 163) and approximately every fifth negative result (n = 626). The Chi-square test for linear trends was used to assess the relationship between SA scores and chlamydia positivity. The median SA scores for chlamydia-positive and negative slides were compared. Results: The median SA scores for chlamydia-positive and -negative slides were 27 and 20, respectively (P < 0.001). Chlamydia positivity rates increased with increasing specimen adequacy scores (0-9, 2.7%; 10-19, 15.1%; 20-29, 24.8%; and 30-45, 31.3%; Chi-square for linear trend: P < 0.001). Conclusion: These results demonstrate a linear relationship between the numbers of cells observed on an endocervical smear and chlamydia positivity rather than the threshold concept in practice. The semiquantitative cytologie technique offers an objective method for further evaluating specimen adequacy for Chlamydia trachomatis testing.
doi_str_mv 10.1097/00007435-199911000-00007
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_69266879</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>44965149</jstor_id><sourcerecordid>44965149</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-c1b10641f9a71e6df30c66338c1db60968f5d984c78816dcddbcd1295e361bbc3</originalsourceid><addsrcrecordid>eNpdkV1P5CAUhonRrOO4P0FDzMa77nIKhXJlJhO_EhMvVq8bCtRh0pYRWo3_fnE6fmS5gXN4zgt5X4QwkN9ApPhD0hKMFhlIKQFSlW1be2gGBRUZK3LYRzMCrMwKAeIQHcW4Ju81gR_oEEjBicjzGVrd-Fe8MPZ5VIPFLn6dGx_wsLJ46dvW6sH5HvsGX_bGaxtenFYt_rux2nW2j1t4uWpV92acwkNQeuU7NSS9BxsH1z9dHKODRrXR_tztc_R4dfmwvMnu7q9vl4u7TDMqh0xDDYQzaKQSYLlpKNGcU1pqMDUnkpdNYWTJtChL4EYbU2sDuSws5VDXms7R-aS7Cf55TI9XnYvatq3qrR9jxWXOeSlkAs_-A9d-DH36W5XnOWM0GZygcoJ08DEG21Sb4DoV3iog1XsU1UcU1WcUUyuNnu70x7qz5tvg5H0Cfu0AFZObTVC9dvGLAykk8ISdTNg6Dj58XjMmeQFM0n_k8Joz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222443743</pqid></control><display><type>article</type><title>How Adequate is Adequate for the Collection of Endocervical Specimens for Chlamydia trachomatis Testing?</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>JSTOR Archive Collection A-Z Listing</source><creator>BEEBE, JAMES L. ; GERSHMAN, KENNETH A. ; KELLEY, JAMES K. ; HAGNER, DINAH ; CREEDE, PAUL</creator><creatorcontrib>BEEBE, JAMES L. ; GERSHMAN, KENNETH A. ; KELLEY, JAMES K. ; HAGNER, DINAH ; CREEDE, PAUL</creatorcontrib><description>Background: Endocervical specimen adequacy has been assessed by subjective criteria that are based on arbitrarily chosen thresholds for the presence of target cells observed on microscopic slide examinations. Goal of this Study: To assess the relationship of chlamydia test positivity to specimen adequacy with the use of a semiquantitative cytologie staining method for assessing endocervical specimen collection cellularity. Study Design: Endocervical specimens for chlamydia testing (PACE 2, GenProbe, San Diego, CA) and for a slide cytologie examination (n = 3,500) were collected in parallel. A semiquantitative cytologie examination to determine a specimen adequacy (SA) score was performed for every chlamydiapositive result (n = 163) and approximately every fifth negative result (n = 626). The Chi-square test for linear trends was used to assess the relationship between SA scores and chlamydia positivity. The median SA scores for chlamydia-positive and negative slides were compared. Results: The median SA scores for chlamydia-positive and -negative slides were 27 and 20, respectively (P &lt; 0.001). Chlamydia positivity rates increased with increasing specimen adequacy scores (0-9, 2.7%; 10-19, 15.1%; 20-29, 24.8%; and 30-45, 31.3%; Chi-square for linear trend: P &lt; 0.001). Conclusion: These results demonstrate a linear relationship between the numbers of cells observed on an endocervical smear and chlamydia positivity rather than the threshold concept in practice. The semiquantitative cytologie technique offers an objective method for further evaluating specimen adequacy for Chlamydia trachomatis testing.</description><identifier>ISSN: 0148-5717</identifier><identifier>EISSN: 1537-4521</identifier><identifier>DOI: 10.1097/00007435-199911000-00007</identifier><identifier>PMID: 10560722</identifier><identifier>CODEN: STRDDM</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Bacterial diseases ; Bacterial diseases of the genital system ; Biological and medical sciences ; Cervix Uteri - microbiology ; Chlamydia Infections - diagnosis ; Chlamydia trachomatis - isolation &amp; purification ; Female ; Human bacterial diseases ; Humans ; Infectious diseases ; Medical sciences ; Medical screening ; Sexually transmitted diseases ; Specimen Handling - standards ; STD ; Vaginal Smears</subject><ispartof>Sexually transmitted diseases, 1999-11, Vol.26 (10), p.579-583</ispartof><rights>Copyright 1999 American Sexually Transmitted Diseases Association</rights><rights>2000 INIST-CNRS</rights><rights>Copyright Lippincott Williams &amp; Wilkins Nov 1999</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-c1b10641f9a71e6df30c66338c1db60968f5d984c78816dcddbcd1295e361bbc3</citedby><cites>FETCH-LOGICAL-c439t-c1b10641f9a71e6df30c66338c1db60968f5d984c78816dcddbcd1295e361bbc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/44965149$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/44965149$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27924,27925,30999,58017,58250</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1197916$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10560722$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BEEBE, JAMES L.</creatorcontrib><creatorcontrib>GERSHMAN, KENNETH A.</creatorcontrib><creatorcontrib>KELLEY, JAMES K.</creatorcontrib><creatorcontrib>HAGNER, DINAH</creatorcontrib><creatorcontrib>CREEDE, PAUL</creatorcontrib><title>How Adequate is Adequate for the Collection of Endocervical Specimens for Chlamydia trachomatis Testing?</title><title>Sexually transmitted diseases</title><addtitle>Sex Transm Dis</addtitle><description>Background: Endocervical specimen adequacy has been assessed by subjective criteria that are based on arbitrarily chosen thresholds for the presence of target cells observed on microscopic slide examinations. Goal of this Study: To assess the relationship of chlamydia test positivity to specimen adequacy with the use of a semiquantitative cytologie staining method for assessing endocervical specimen collection cellularity. Study Design: Endocervical specimens for chlamydia testing (PACE 2, GenProbe, San Diego, CA) and for a slide cytologie examination (n = 3,500) were collected in parallel. A semiquantitative cytologie examination to determine a specimen adequacy (SA) score was performed for every chlamydiapositive result (n = 163) and approximately every fifth negative result (n = 626). The Chi-square test for linear trends was used to assess the relationship between SA scores and chlamydia positivity. The median SA scores for chlamydia-positive and negative slides were compared. Results: The median SA scores for chlamydia-positive and -negative slides were 27 and 20, respectively (P &lt; 0.001). Chlamydia positivity rates increased with increasing specimen adequacy scores (0-9, 2.7%; 10-19, 15.1%; 20-29, 24.8%; and 30-45, 31.3%; Chi-square for linear trend: P &lt; 0.001). Conclusion: These results demonstrate a linear relationship between the numbers of cells observed on an endocervical smear and chlamydia positivity rather than the threshold concept in practice. The semiquantitative cytologie technique offers an objective method for further evaluating specimen adequacy for Chlamydia trachomatis testing.</description><subject>Bacterial diseases</subject><subject>Bacterial diseases of the genital system</subject><subject>Biological and medical sciences</subject><subject>Cervix Uteri - microbiology</subject><subject>Chlamydia Infections - diagnosis</subject><subject>Chlamydia trachomatis - isolation &amp; purification</subject><subject>Female</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Medical screening</subject><subject>Sexually transmitted diseases</subject><subject>Specimen Handling - standards</subject><subject>STD</subject><subject>Vaginal Smears</subject><issn>0148-5717</issn><issn>1537-4521</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNpdkV1P5CAUhonRrOO4P0FDzMa77nIKhXJlJhO_EhMvVq8bCtRh0pYRWo3_fnE6fmS5gXN4zgt5X4QwkN9ApPhD0hKMFhlIKQFSlW1be2gGBRUZK3LYRzMCrMwKAeIQHcW4Ju81gR_oEEjBicjzGVrd-Fe8MPZ5VIPFLn6dGx_wsLJ46dvW6sH5HvsGX_bGaxtenFYt_rux2nW2j1t4uWpV92acwkNQeuU7NSS9BxsH1z9dHKODRrXR_tztc_R4dfmwvMnu7q9vl4u7TDMqh0xDDYQzaKQSYLlpKNGcU1pqMDUnkpdNYWTJtChL4EYbU2sDuSws5VDXms7R-aS7Cf55TI9XnYvatq3qrR9jxWXOeSlkAs_-A9d-DH36W5XnOWM0GZygcoJ08DEG21Sb4DoV3iog1XsU1UcU1WcUUyuNnu70x7qz5tvg5H0Cfu0AFZObTVC9dvGLAykk8ISdTNg6Dj58XjMmeQFM0n_k8Joz</recordid><startdate>19991101</startdate><enddate>19991101</enddate><creator>BEEBE, JAMES L.</creator><creator>GERSHMAN, KENNETH A.</creator><creator>KELLEY, JAMES K.</creator><creator>HAGNER, DINAH</creator><creator>CREEDE, PAUL</creator><general>Lippincott Williams &amp; Wilkins</general><general>Lippincott</general><general>Lippincott Williams &amp; Wilkins Ovid Technologies</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7QL</scope><scope>7T2</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>19991101</creationdate><title>How Adequate is Adequate for the Collection of Endocervical Specimens for Chlamydia trachomatis Testing?</title><author>BEEBE, JAMES L. ; GERSHMAN, KENNETH A. ; KELLEY, JAMES K. ; HAGNER, DINAH ; CREEDE, PAUL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-c1b10641f9a71e6df30c66338c1db60968f5d984c78816dcddbcd1295e361bbc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Bacterial diseases</topic><topic>Bacterial diseases of the genital system</topic><topic>Biological and medical sciences</topic><topic>Cervix Uteri - microbiology</topic><topic>Chlamydia Infections - diagnosis</topic><topic>Chlamydia trachomatis - isolation &amp; purification</topic><topic>Female</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Medical screening</topic><topic>Sexually transmitted diseases</topic><topic>Specimen Handling - standards</topic><topic>STD</topic><topic>Vaginal Smears</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BEEBE, JAMES L.</creatorcontrib><creatorcontrib>GERSHMAN, KENNETH A.</creatorcontrib><creatorcontrib>KELLEY, JAMES K.</creatorcontrib><creatorcontrib>HAGNER, DINAH</creatorcontrib><creatorcontrib>CREEDE, PAUL</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Sexually transmitted diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BEEBE, JAMES L.</au><au>GERSHMAN, KENNETH A.</au><au>KELLEY, JAMES K.</au><au>HAGNER, DINAH</au><au>CREEDE, PAUL</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>How Adequate is Adequate for the Collection of Endocervical Specimens for Chlamydia trachomatis Testing?</atitle><jtitle>Sexually transmitted diseases</jtitle><addtitle>Sex Transm Dis</addtitle><date>1999-11-01</date><risdate>1999</risdate><volume>26</volume><issue>10</issue><spage>579</spage><epage>583</epage><pages>579-583</pages><issn>0148-5717</issn><eissn>1537-4521</eissn><coden>STRDDM</coden><abstract>Background: Endocervical specimen adequacy has been assessed by subjective criteria that are based on arbitrarily chosen thresholds for the presence of target cells observed on microscopic slide examinations. Goal of this Study: To assess the relationship of chlamydia test positivity to specimen adequacy with the use of a semiquantitative cytologie staining method for assessing endocervical specimen collection cellularity. Study Design: Endocervical specimens for chlamydia testing (PACE 2, GenProbe, San Diego, CA) and for a slide cytologie examination (n = 3,500) were collected in parallel. A semiquantitative cytologie examination to determine a specimen adequacy (SA) score was performed for every chlamydiapositive result (n = 163) and approximately every fifth negative result (n = 626). The Chi-square test for linear trends was used to assess the relationship between SA scores and chlamydia positivity. The median SA scores for chlamydia-positive and negative slides were compared. Results: The median SA scores for chlamydia-positive and -negative slides were 27 and 20, respectively (P &lt; 0.001). Chlamydia positivity rates increased with increasing specimen adequacy scores (0-9, 2.7%; 10-19, 15.1%; 20-29, 24.8%; and 30-45, 31.3%; Chi-square for linear trend: P &lt; 0.001). Conclusion: These results demonstrate a linear relationship between the numbers of cells observed on an endocervical smear and chlamydia positivity rather than the threshold concept in practice. The semiquantitative cytologie technique offers an objective method for further evaluating specimen adequacy for Chlamydia trachomatis testing.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>10560722</pmid><doi>10.1097/00007435-199911000-00007</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0148-5717
ispartof Sexually transmitted diseases, 1999-11, Vol.26 (10), p.579-583
issn 0148-5717
1537-4521
language eng
recordid cdi_proquest_miscellaneous_69266879
source MEDLINE; Journals@Ovid Complete; Applied Social Sciences Index & Abstracts (ASSIA); JSTOR Archive Collection A-Z Listing
subjects Bacterial diseases
Bacterial diseases of the genital system
Biological and medical sciences
Cervix Uteri - microbiology
Chlamydia Infections - diagnosis
Chlamydia trachomatis - isolation & purification
Female
Human bacterial diseases
Humans
Infectious diseases
Medical sciences
Medical screening
Sexually transmitted diseases
Specimen Handling - standards
STD
Vaginal Smears
title How Adequate is Adequate for the Collection of Endocervical Specimens for Chlamydia trachomatis Testing?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A20%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=How%20Adequate%20is%20Adequate%20for%20the%20Collection%20of%20Endocervical%20Specimens%20for%20Chlamydia%20trachomatis%20Testing?&rft.jtitle=Sexually%20transmitted%20diseases&rft.au=BEEBE,%20JAMES%20L.&rft.date=1999-11-01&rft.volume=26&rft.issue=10&rft.spage=579&rft.epage=583&rft.pages=579-583&rft.issn=0148-5717&rft.eissn=1537-4521&rft.coden=STRDDM&rft_id=info:doi/10.1097/00007435-199911000-00007&rft_dat=%3Cjstor_proqu%3E44965149%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=222443743&rft_id=info:pmid/10560722&rft_jstor_id=44965149&rfr_iscdi=true